Filing Flows

Filing Flows › Merck (MRK) › Stock forecast & fair value

Merck (MRK) stock forecast and fair value

Merck (MRK) trades at $146.73. 26 analysts' median price target is $165.00 (+12%), from $105.00 to $186.00. Across 18 valuation methods the middle fair value is $40.72 (-72%).

Price$146.73
Median target$165.00
Fair value, middle$40.72
EPS beat rate100%
Merck fair value by method (price $146.73)Merck fair value by method (price $146.73)low – highpoint estimateP/E vs peers$17.47P/E vs peers, weighted$30.38P/E vs peers, matched$40.72EV/Sales vs peers$88.43EV/Sales vs peers, weighted$133.66EV/Sales vs peers, matched$97.99Residual income$15.92Analysts' price targets$161.53Our model (Rotation forecast)$153.52Owner earnings capitalized$15.92

Fair value by method

MethodLowPointHighvs price
P/E vs peers$12.72$17.47$40.92-88%
P/E vs peers, weighted$17.83$30.38$44.47-79%
P/E vs peers, matched$22.63$40.72$44.88-72%
EV/Sales vs peers$44.21$88.43$197.26-40%
EV/Sales vs peers, weighted$68.37$133.66$233.51-9%
EV/Sales vs peers, matched$70.45$97.99$181.64-33%
Residual income$15.33$15.92$16.55-89%
Analysts' price targets$105.00$161.53$186.00+10%
Our model (Rotation forecast)$115.77$153.52$203.59+5%
Owner earnings capitalized$13.23$15.92$19.98-89%

Merck's latest quarter

Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for MRK stock?

The median of 26 analysts' 12-month targets is $165.00, +12% from $146.73; the range is $105.00 to $186.00. The average rating is buy.

What is Merck's fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $161.53, with a middle value of $40.72 against a price of $146.73. Each method's assumptions are on the page.

Does Merck usually beat earnings estimates?

It beat the consensus EPS estimate in 100% of the quarters on record.

Is MRK stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.